nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—PTGS2—atherosclerosis	0.578	1	CbGaD
Clodronate—SLC25A6—connective tissue—atherosclerosis	0.00826	0.0885	CbGeAlD
Clodronate—SLC25A6—cardiovascular system—atherosclerosis	0.00718	0.077	CbGeAlD
Clodronate—SLC25A5—connective tissue—atherosclerosis	0.00718	0.077	CbGeAlD
Clodronate—SLC25A6—adipose tissue—atherosclerosis	0.00633	0.0679	CbGeAlD
Clodronate—SLC25A5—cardiovascular system—atherosclerosis	0.00625	0.067	CbGeAlD
Clodronate—PTGS2—leg—atherosclerosis	0.00618	0.0663	CbGeAlD
Clodronate—SLC25A4—cardiovascular system—atherosclerosis	0.00586	0.0628	CbGeAlD
Clodronate—PTGS2—hindlimb—atherosclerosis	0.00552	0.0592	CbGeAlD
Clodronate—SLC25A5—adipose tissue—atherosclerosis	0.00551	0.0591	CbGeAlD
Clodronate—SLC25A4—adipose tissue—atherosclerosis	0.00516	0.0554	CbGeAlD
Clodronate—Foetor hepaticus—Ezetimibe—atherosclerosis	0.00516	0.0331	CcSEcCtD
Clodronate—Foetor hepaticus—Simvastatin—atherosclerosis	0.00492	0.0316	CcSEcCtD
Clodronate—PTGS2—appendage—atherosclerosis	0.00474	0.0508	CbGeAlD
Clodronate—SLC25A4—Simvastatin—Pravastatin—atherosclerosis	0.00457	0.5	CbGdCrCtD
Clodronate—SLC25A4—Simvastatin—Lovastatin—atherosclerosis	0.00457	0.5	CbGdCrCtD
Clodronate—Foetor hepaticus—Pravastatin—atherosclerosis	0.00445	0.0286	CcSEcCtD
Clodronate—SLC25A6—liver—atherosclerosis	0.00444	0.0476	CbGeAlD
Clodronate—Gastrointestinal symptom NOS—Niacin—atherosclerosis	0.00436	0.028	CcSEcCtD
Clodronate—Liver disorder—Ezetimibe—atherosclerosis	0.00429	0.0276	CcSEcCtD
Clodronate—Liver disorder—Simvastatin—atherosclerosis	0.00409	0.0263	CcSEcCtD
Clodronate—Proteinuria—Rosuvastatin—atherosclerosis	0.00401	0.0257	CcSEcCtD
Clodronate—Protein urine present—Rosuvastatin—atherosclerosis	0.00395	0.0254	CcSEcCtD
Clodronate—SLC25A5—liver—atherosclerosis	0.00386	0.0414	CbGeAlD
Clodronate—Liver disorder—Pravastatin—atherosclerosis	0.0037	0.0238	CcSEcCtD
Clodronate—SLC25A4—liver—atherosclerosis	0.00362	0.0388	CbGeAlD
Clodronate—Neoplasm malignant—Ezetimibe—atherosclerosis	0.00343	0.022	CcSEcCtD
Clodronate—PTGS2—artery—atherosclerosis	0.00339	0.0363	CbGeAlD
Clodronate—Proteinuria—Simvastatin—atherosclerosis	0.00318	0.0204	CcSEcCtD
Clodronate—Protein urine present—Simvastatin—atherosclerosis	0.00313	0.0201	CcSEcCtD
Clodronate—Hepatocellular injury—Ezetimibe—atherosclerosis	0.00293	0.0188	CcSEcCtD
Clodronate—PTGS2—endothelium—atherosclerosis	0.00286	0.0307	CbGeAlD
Clodronate—Hepatocellular injury—Simvastatin—atherosclerosis	0.00279	0.0179	CcSEcCtD
Clodronate—Renal failure acute—Rosuvastatin—atherosclerosis	0.00277	0.0178	CcSEcCtD
Clodronate—PTGS2—blood vessel—atherosclerosis	0.00264	0.0283	CbGeAlD
Clodronate—Hepatocellular injury—Pravastatin—atherosclerosis	0.00252	0.0162	CcSEcCtD
Clodronate—Hepatic function abnormal—Lovastatin—atherosclerosis	0.00248	0.0159	CcSEcCtD
Clodronate—Hepatic function abnormal—Simvastatin—atherosclerosis	0.00232	0.0149	CcSEcCtD
Clodronate—Hepatic function abnormal—Niacin—atherosclerosis	0.00213	0.0137	CcSEcCtD
Clodronate—Hepatic function abnormal—Pravastatin—atherosclerosis	0.0021	0.0135	CcSEcCtD
Clodronate—Renal failure acute—Pravastatin—atherosclerosis	0.00198	0.0127	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.00187	0.012	CcSEcCtD
Clodronate—Pharyngitis—Rosuvastatin—atherosclerosis	0.00175	0.0113	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00162	0.0104	CcSEcCtD
Clodronate—Dysphagia—Niacin—atherosclerosis	0.00161	0.0103	CcSEcCtD
Clodronate—Pharyngitis—Ezetimibe—atherosclerosis	0.00146	0.00937	CcSEcCtD
Clodronate—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00144	0.00928	CcSEcCtD
Clodronate—Angioedema—Rosuvastatin—atherosclerosis	0.00141	0.00904	CcSEcCtD
Clodronate—PTGS2—connective tissue—atherosclerosis	0.00135	0.0145	CbGeAlD
Clodronate—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00132	0.00851	CcSEcCtD
Clodronate—Pharyngitis—Pravastatin—atherosclerosis	0.00126	0.00808	CcSEcCtD
Clodronate—Infection—Rosuvastatin—atherosclerosis	0.00125	0.00802	CcSEcCtD
Clodronate—Angioedema—Lovastatin—atherosclerosis	0.00119	0.00766	CcSEcCtD
Clodronate—Anaemia—Ezetimibe—atherosclerosis	0.00118	0.0076	CcSEcCtD
Clodronate—PTGS2—cardiovascular system—atherosclerosis	0.00118	0.0126	CbGeAlD
Clodronate—Angioedema—Ezetimibe—atherosclerosis	0.00117	0.00751	CcSEcCtD
Clodronate—Anaemia—Simvastatin—atherosclerosis	0.00113	0.00724	CcSEcCtD
Clodronate—Angioedema—Simvastatin—atherosclerosis	0.00111	0.00716	CcSEcCtD
Clodronate—Dyspepsia—Rosuvastatin—atherosclerosis	0.00111	0.0071	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00108	0.00695	CcSEcCtD
Clodronate—Infection—Lovastatin—atherosclerosis	0.00106	0.00679	CcSEcCtD
Clodronate—PTGS2—adipose tissue—atherosclerosis	0.00104	0.0111	CbGeAlD
Clodronate—Infection—Ezetimibe—atherosclerosis	0.00104	0.00666	CcSEcCtD
Clodronate—Angioedema—Niacin—atherosclerosis	0.00102	0.00658	CcSEcCtD
Clodronate—Anaemia—Pravastatin—atherosclerosis	0.00102	0.00655	CcSEcCtD
Clodronate—Anorexia—Lovastatin—atherosclerosis	0.00101	0.00652	CcSEcCtD
Clodronate—Skin disorder—Ezetimibe—atherosclerosis	0.00101	0.00652	CcSEcCtD
Clodronate—Angioedema—Pravastatin—atherosclerosis	0.00101	0.00648	CcSEcCtD
Clodronate—Urticaria—Rosuvastatin—atherosclerosis	0.000998	0.00641	CcSEcCtD
Clodronate—Abdominal pain—Rosuvastatin—atherosclerosis	0.000993	0.00638	CcSEcCtD
Clodronate—Infection—Simvastatin—atherosclerosis	0.000989	0.00636	CcSEcCtD
Clodronate—Anorexia—Simvastatin—atherosclerosis	0.000949	0.0061	CcSEcCtD
Clodronate—Dyspnoea—Lovastatin—atherosclerosis	0.000949	0.0061	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000947	0.00609	CcSEcCtD
Clodronate—Dyspepsia—Lovastatin—atherosclerosis	0.000937	0.00602	CcSEcCtD
Clodronate—Dyspnoea—Ezetimibe—atherosclerosis	0.000931	0.00598	CcSEcCtD
Clodronate—Decreased appetite—Lovastatin—atherosclerosis	0.000925	0.00595	CcSEcCtD
Clodronate—Dyspepsia—Ezetimibe—atherosclerosis	0.000919	0.00591	CcSEcCtD
Clodronate—Decreased appetite—Ezetimibe—atherosclerosis	0.000908	0.00583	CcSEcCtD
Clodronate—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000901	0.00579	CcSEcCtD
Clodronate—Infection—Pravastatin—atherosclerosis	0.000894	0.00575	CcSEcCtD
Clodronate—Pruritus—Rosuvastatin—atherosclerosis	0.000889	0.00571	CcSEcCtD
Clodronate—Skin disorder—Niacin—atherosclerosis	0.000888	0.00571	CcSEcCtD
Clodronate—Dyspnoea—Simvastatin—atherosclerosis	0.000888	0.0057	CcSEcCtD
Clodronate—Dyspepsia—Simvastatin—atherosclerosis	0.000876	0.00563	CcSEcCtD
Clodronate—Anorexia—Niacin—atherosclerosis	0.000871	0.0056	CcSEcCtD
Clodronate—Decreased appetite—Simvastatin—atherosclerosis	0.000866	0.00556	CcSEcCtD
Clodronate—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00086	0.00552	CcSEcCtD
Clodronate—Diarrhoea—Rosuvastatin—atherosclerosis	0.000859	0.00552	CcSEcCtD
Clodronate—Anorexia—Pravastatin—atherosclerosis	0.000858	0.00551	CcSEcCtD
Clodronate—Urticaria—Lovastatin—atherosclerosis	0.000846	0.00543	CcSEcCtD
Clodronate—Abdominal pain—Lovastatin—atherosclerosis	0.000842	0.00541	CcSEcCtD
Clodronate—Urticaria—Ezetimibe—atherosclerosis	0.000829	0.00533	CcSEcCtD
Clodronate—Abdominal pain—Ezetimibe—atherosclerosis	0.000825	0.0053	CcSEcCtD
Clodronate—Dyspnoea—Niacin—atherosclerosis	0.000815	0.00524	CcSEcCtD
Clodronate—Dyspepsia—Niacin—atherosclerosis	0.000805	0.00517	CcSEcCtD
Clodronate—Dyspnoea—Pravastatin—atherosclerosis	0.000803	0.00516	CcSEcCtD
Clodronate—Decreased appetite—Niacin—atherosclerosis	0.000795	0.00511	CcSEcCtD
Clodronate—Dyspepsia—Pravastatin—atherosclerosis	0.000792	0.00509	CcSEcCtD
Clodronate—Rash—Rosuvastatin—atherosclerosis	0.000792	0.00509	CcSEcCtD
Clodronate—Dermatitis—Rosuvastatin—atherosclerosis	0.000791	0.00508	CcSEcCtD
Clodronate—Urticaria—Simvastatin—atherosclerosis	0.000791	0.00508	CcSEcCtD
Clodronate—Gastrointestinal disorder—Niacin—atherosclerosis	0.000789	0.00507	CcSEcCtD
Clodronate—Abdominal pain—Simvastatin—atherosclerosis	0.000787	0.00506	CcSEcCtD
Clodronate—Decreased appetite—Pravastatin—atherosclerosis	0.000783	0.00503	CcSEcCtD
Clodronate—Pruritus—Lovastatin—atherosclerosis	0.000753	0.00484	CcSEcCtD
Clodronate—Nausea—Rosuvastatin—atherosclerosis	0.000746	0.00479	CcSEcCtD
Clodronate—Pruritus—Ezetimibe—atherosclerosis	0.000739	0.00475	CcSEcCtD
Clodronate—Diarrhoea—Lovastatin—atherosclerosis	0.000728	0.00468	CcSEcCtD
Clodronate—PTGS2—liver—atherosclerosis	0.000728	0.0078	CbGeAlD
Clodronate—Urticaria—Niacin—atherosclerosis	0.000726	0.00467	CcSEcCtD
Clodronate—Abdominal pain—Niacin—atherosclerosis	0.000723	0.00464	CcSEcCtD
Clodronate—Urticaria—Pravastatin—atherosclerosis	0.000715	0.00459	CcSEcCtD
Clodronate—Diarrhoea—Ezetimibe—atherosclerosis	0.000714	0.00459	CcSEcCtD
Clodronate—Abdominal pain—Pravastatin—atherosclerosis	0.000712	0.00457	CcSEcCtD
Clodronate—Pruritus—Simvastatin—atherosclerosis	0.000704	0.00453	CcSEcCtD
Clodronate—Diarrhoea—Simvastatin—atherosclerosis	0.000681	0.00438	CcSEcCtD
Clodronate—Vomiting—Lovastatin—atherosclerosis	0.000677	0.00435	CcSEcCtD
Clodronate—Rash—Lovastatin—atherosclerosis	0.000671	0.00431	CcSEcCtD
Clodronate—Dermatitis—Lovastatin—atherosclerosis	0.000671	0.00431	CcSEcCtD
Clodronate—Vomiting—Ezetimibe—atherosclerosis	0.000664	0.00427	CcSEcCtD
Clodronate—Rash—Ezetimibe—atherosclerosis	0.000658	0.00423	CcSEcCtD
Clodronate—Dermatitis—Ezetimibe—atherosclerosis	0.000658	0.00423	CcSEcCtD
Clodronate—Pruritus—Niacin—atherosclerosis	0.000647	0.00416	CcSEcCtD
Clodronate—Pruritus—Pravastatin—atherosclerosis	0.000637	0.00409	CcSEcCtD
Clodronate—Vomiting—Simvastatin—atherosclerosis	0.000633	0.00407	CcSEcCtD
Clodronate—Nausea—Lovastatin—atherosclerosis	0.000632	0.00406	CcSEcCtD
Clodronate—Rash—Simvastatin—atherosclerosis	0.000628	0.00403	CcSEcCtD
Clodronate—Dermatitis—Simvastatin—atherosclerosis	0.000627	0.00403	CcSEcCtD
Clodronate—Diarrhoea—Niacin—atherosclerosis	0.000626	0.00402	CcSEcCtD
Clodronate—Nausea—Ezetimibe—atherosclerosis	0.00062	0.00398	CcSEcCtD
Clodronate—Diarrhoea—Pravastatin—atherosclerosis	0.000616	0.00396	CcSEcCtD
Clodronate—Nausea—Simvastatin—atherosclerosis	0.000591	0.0038	CcSEcCtD
Clodronate—Vomiting—Niacin—atherosclerosis	0.000581	0.00373	CcSEcCtD
Clodronate—Rash—Niacin—atherosclerosis	0.000576	0.0037	CcSEcCtD
Clodronate—Dermatitis—Niacin—atherosclerosis	0.000576	0.0037	CcSEcCtD
Clodronate—Vomiting—Pravastatin—atherosclerosis	0.000572	0.00368	CcSEcCtD
Clodronate—Rash—Pravastatin—atherosclerosis	0.000568	0.00365	CcSEcCtD
Clodronate—Dermatitis—Pravastatin—atherosclerosis	0.000567	0.00364	CcSEcCtD
Clodronate—Nausea—Niacin—atherosclerosis	0.000543	0.00349	CcSEcCtD
Clodronate—Nausea—Pravastatin—atherosclerosis	0.000535	0.00344	CcSEcCtD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—atherosclerosis	0.00018	0.00109	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GPX1—atherosclerosis	0.000178	0.00109	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PRKCG—atherosclerosis	0.000178	0.00108	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CD36—atherosclerosis	0.000174	0.00106	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—HMGCR—atherosclerosis	0.000171	0.00104	CbGpPWpGaD
Clodronate—SLC25A5—Disease—NOS2—atherosclerosis	0.000171	0.00104	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—INS—atherosclerosis	0.000169	0.00103	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.000168	0.00102	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—HMOX1—atherosclerosis	0.000168	0.00102	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—CCL2—atherosclerosis	0.000167	0.00101	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—INS—atherosclerosis	0.000166	0.00101	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—CXCL8—atherosclerosis	0.000166	0.00101	CbGpPWpGaD
Clodronate—SLC25A6—Disease—MTHFR—atherosclerosis	0.000165	0.001	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—MTHFR—atherosclerosis	0.000165	0.001	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—CCL2—atherosclerosis	0.000164	0.000996	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PPARA—atherosclerosis	0.000162	0.000984	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—IGF1—atherosclerosis	0.000161	0.000979	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—APOB—atherosclerosis	0.00016	0.000977	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PDGFB—atherosclerosis	0.00016	0.000976	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—LEP—atherosclerosis	0.000157	0.000954	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—AGT—atherosclerosis	0.000156	0.000953	CbGpPWpGaD
Clodronate—SLC25A5—Disease—INS—atherosclerosis	0.000156	0.000952	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GSTM1—atherosclerosis	0.000156	0.000951	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—MMP2—atherosclerosis	0.000156	0.000947	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—SERPINE1—atherosclerosis	0.000155	0.000947	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—ALB—atherosclerosis	0.000155	0.000945	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	0.000154	0.000938	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TLR4—atherosclerosis	0.000154	0.000935	CbGpPWpGaD
Clodronate—SLC25A6—Disease—APOE—atherosclerosis	0.000153	0.000934	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—APOE—atherosclerosis	0.000153	0.000933	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—LPL—atherosclerosis	0.000153	0.000933	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ABCA1—atherosclerosis	0.000152	0.000928	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CAV1—atherosclerosis	0.000152	0.000925	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CAV1—atherosclerosis	0.000152	0.000925	CbGpPWpGaD
Clodronate—SLC25A6—Disease—APOA1—atherosclerosis	0.000152	0.000923	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—APOA1—atherosclerosis	0.000152	0.000923	CbGpPWpGaD
Clodronate—SLC25A4—Disease—APOB—atherosclerosis	0.00015	0.000911	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GPX1—atherosclerosis	0.00015	0.00091	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—ICAM1—atherosclerosis	0.000147	0.000896	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—NOS2—atherosclerosis	0.000146	0.000889	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CD36—atherosclerosis	0.000146	0.000887	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000145	0.00088	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—atherosclerosis	0.000144	0.000877	CbGpPWpGaD
Clodronate—SLC25A5—Disease—SERPINE1—atherosclerosis	0.000144	0.000875	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NOS2—atherosclerosis	0.000143	0.00087	CbGpPWpGaD
Clodronate—SLC25A4—Disease—LPL—atherosclerosis	0.000143	0.00087	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IFNG—atherosclerosis	0.000142	0.000862	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PRKCG—atherosclerosis	0.000139	0.000846	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PIK3CG—atherosclerosis	0.000138	0.000842	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—MTHFR—atherosclerosis	0.000138	0.00084	CbGpPWpGaD
Clodronate—SLC25A5—Disease—NOS3—atherosclerosis	0.000137	0.000835	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000136	0.000828	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000136	0.000828	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PPARA—atherosclerosis	0.000135	0.000824	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000135	0.000823	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PPARG—atherosclerosis	0.000134	0.000813	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000133	0.000812	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CCL2—atherosclerosis	0.000132	0.000802	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—AGT—atherosclerosis	0.000131	0.000798	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000131	0.000798	CbGpPWpGaD
Clodronate—SLC25A6—Disease—INS—atherosclerosis	0.000131	0.000798	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—INS—atherosclerosis	0.000131	0.000797	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—HMOX1—atherosclerosis	0.000131	0.000796	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—CXCL8—atherosclerosis	0.000129	0.000787	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MTHFR—atherosclerosis	0.000129	0.000783	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—APOE—atherosclerosis	0.000128	0.000782	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CAV1—atherosclerosis	0.000127	0.000775	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—APOA1—atherosclerosis	0.000127	0.000773	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL1B—atherosclerosis	0.000126	0.000769	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PTGS2—atherosclerosis	0.000125	0.000764	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—APOB—atherosclerosis	0.000125	0.000763	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PDGFB—atherosclerosis	0.000125	0.000762	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GSTM1—atherosclerosis	0.000122	0.000742	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000121	0.000738	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.00012	0.000733	CbGpPWpGaD
Clodronate—SLC25A6—Disease—SERPINE1—atherosclerosis	0.00012	0.000733	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—ALB—atherosclerosis	0.00012	0.000731	CbGpPWpGaD
Clodronate—SLC25A4—Disease—APOE—atherosclerosis	0.00012	0.000729	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—LPL—atherosclerosis	0.00012	0.000728	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CAV1—atherosclerosis	0.000119	0.000722	CbGpPWpGaD
Clodronate—SLC25A4—Disease—APOA1—atherosclerosis	0.000118	0.000721	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—NFKB1—atherosclerosis	0.000118	0.000718	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GPX1—atherosclerosis	0.000117	0.000711	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PIK3CG—atherosclerosis	0.000116	0.000706	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NOS3—atherosclerosis	0.000115	0.0007	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—NOS3—atherosclerosis	0.000115	0.000699	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000115	0.000699	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000115	0.000699	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000115	0.000699	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000115	0.000699	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CD36—atherosclerosis	0.000114	0.000692	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000113	0.000691	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IFNG—atherosclerosis	0.000112	0.000682	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PPARG—atherosclerosis	0.000112	0.000681	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NOS2—atherosclerosis	0.000112	0.000679	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—INS—atherosclerosis	0.00011	0.000668	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.00011	0.000667	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—MTHFR—atherosclerosis	0.000108	0.000656	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PPARA—atherosclerosis	0.000106	0.000643	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PTGS2—atherosclerosis	0.000105	0.00064	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PTGS2—atherosclerosis	0.000105	0.00064	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.000105	0.00064	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CXCL8—atherosclerosis	0.000104	0.000634	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—AGT—atherosclerosis	0.000102	0.000623	CbGpPWpGaD
Clodronate—SLC25A4—Disease—INS—atherosclerosis	0.000102	0.000623	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.000102	0.00062	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000101	0.000616	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ALB—atherosclerosis	0.000101	0.000613	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—APOE—atherosclerosis	0.0001	0.000611	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL1B—atherosclerosis	9.99e-05	0.000608	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—LDLRAP1—atherosclerosis	9.99e-05	0.000608	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CAV1—atherosclerosis	9.94e-05	0.000605	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—APOA1—atherosclerosis	9.91e-05	0.000604	CbGpPWpGaD
Clodronate—SLC25A5—Disease—STAT3—atherosclerosis	9.78e-05	0.000596	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	9.76e-05	0.000595	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—NOS3—atherosclerosis	9.62e-05	0.000586	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—MMP9—atherosclerosis	9.42e-05	0.000574	CbGpPWpGaD
Clodronate—SLC25A4—Disease—SERPINE1—atherosclerosis	9.4e-05	0.000572	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PLTP—atherosclerosis	9.39e-05	0.000572	CbGpPWpGaD
Clodronate—SLC25A5—Disease—MAPK3—atherosclerosis	9.34e-05	0.000569	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—TNF—atherosclerosis	9.17e-05	0.000558	CbGpPWpGaD
Clodronate—SLC25A5—Disease—TGFB1—atherosclerosis	9.07e-05	0.000552	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3CG—atherosclerosis	9.05e-05	0.000551	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NOS3—atherosclerosis	8.97e-05	0.000546	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	8.81e-05	0.000536	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PTGS2—atherosclerosis	8.8e-05	0.000536	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PPARG—atherosclerosis	8.73e-05	0.000532	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	8.7e-05	0.00053	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	8.65e-05	0.000527	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	8.6e-05	0.000523	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—INS—atherosclerosis	8.57e-05	0.000522	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	8.4e-05	0.000511	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PTGS2—atherosclerosis	8.2e-05	0.0005	CbGpPWpGaD
Clodronate—SLC25A6—Disease—STAT3—atherosclerosis	8.2e-05	0.000499	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—LTA4H—atherosclerosis	8.14e-05	0.000496	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCG8—atherosclerosis	8.14e-05	0.000496	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	8.04e-05	0.00049	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—MAPK3—atherosclerosis	8e-05	0.000487	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ALB—atherosclerosis	7.85e-05	0.000478	CbGpPWpGaD
Clodronate—SLC25A6—Disease—MAPK3—atherosclerosis	7.83e-05	0.000477	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TGFB1—atherosclerosis	7.76e-05	0.000473	CbGpPWpGaD
Clodronate—SLC25A6—Disease—TGFB1—atherosclerosis	7.6e-05	0.000463	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	7.59e-05	0.000462	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—NOS3—atherosclerosis	7.51e-05	0.000457	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL6—atherosclerosis	7.4e-05	0.00045	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TNF—atherosclerosis	7.25e-05	0.000441	CbGpPWpGaD
Clodronate—PTGS2—Disease—APOA4—atherosclerosis	7.09e-05	0.000432	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PTGS2—atherosclerosis	6.87e-05	0.000418	CbGpPWpGaD
Clodronate—SLC25A5—Disease—IL6—atherosclerosis	6.83e-05	0.000416	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	6.77e-05	0.000412	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCG1—atherosclerosis	6.44e-05	0.000392	CbGpPWpGaD
Clodronate—SLC25A4—Disease—STAT3—atherosclerosis	6.4e-05	0.00039	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	6.34e-05	0.000386	CbGpPWpGaD
Clodronate—SLC25A5—Disease—AKT1—atherosclerosis	6.3e-05	0.000384	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	6.23e-05	0.000379	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MAPK3—atherosclerosis	6.11e-05	0.000372	CbGpPWpGaD
Clodronate—PTGS2—Disease—APOA2—atherosclerosis	6.11e-05	0.000372	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—LCAT—atherosclerosis	6.05e-05	0.000369	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—FABP4—atherosclerosis	6.05e-05	0.000369	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APOA4—atherosclerosis	5.94e-05	0.000362	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TGFB1—atherosclerosis	5.93e-05	0.000361	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL6—atherosclerosis	5.85e-05	0.000356	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP7A1—atherosclerosis	5.84e-05	0.000355	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	5.75e-05	0.00035	CbGpPWpGaD
Clodronate—SLC25A6—Disease—IL6—atherosclerosis	5.73e-05	0.000349	CbGpPWpGaD
Clodronate—PTGS2—Disease—BGN—atherosclerosis	5.64e-05	0.000344	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	5.56e-05	0.000339	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	5.44e-05	0.000331	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP27A1—atherosclerosis	5.39e-05	0.000328	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	5.31e-05	0.000323	CbGpPWpGaD
Clodronate—SLC25A6—Disease—AKT1—atherosclerosis	5.28e-05	0.000322	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	5.28e-05	0.000322	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—AKT1—atherosclerosis	5.28e-05	0.000321	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	5.18e-05	0.000315	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALOX15—atherosclerosis	5.11e-05	0.000311	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PLA2G2A—atherosclerosis	5.11e-05	0.000311	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALOX5AP—atherosclerosis	5.11e-05	0.000311	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APOA2—atherosclerosis	5.11e-05	0.000311	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCG5—atherosclerosis	5.05e-05	0.000308	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	5.05e-05	0.000307	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	4.93e-05	0.0003	CbGpPWpGaD
Clodronate—PTGS2—Disease—CST3—atherosclerosis	4.92e-05	0.000299	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—LPA—atherosclerosis	4.88e-05	0.000297	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—BGN—atherosclerosis	4.72e-05	0.000288	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	4.69e-05	0.000286	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APOA5—atherosclerosis	4.68e-05	0.000285	CbGpPWpGaD
Clodronate—PTGS2—Disease—NAMPT—atherosclerosis	4.66e-05	0.000284	CbGpPWpGaD
Clodronate—PTGS2—Disease—APOC3—atherosclerosis	4.6e-05	0.00028	CbGpPWpGaD
Clodronate—PTGS2—Disease—LDLR—atherosclerosis	4.57e-05	0.000278	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	4.54e-05	0.000277	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PLA2G1B—atherosclerosis	4.5e-05	0.000274	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IL6—atherosclerosis	4.47e-05	0.000272	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	4.45e-05	0.000271	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—AKT1—atherosclerosis	4.42e-05	0.000269	CbGpPWpGaD
Clodronate—PTGS2—Disease—HSPA1B—atherosclerosis	4.41e-05	0.000269	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	4.41e-05	0.000269	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	4.4e-05	0.000268	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALOX5—atherosclerosis	4.35e-05	0.000265	CbGpPWpGaD
Clodronate—PTGS2—Disease—NCF1—atherosclerosis	4.28e-05	0.00026	CbGpPWpGaD
Clodronate—SLC25A4—Disease—AKT1—atherosclerosis	4.12e-05	0.000251	CbGpPWpGaD
Clodronate—PTGS2—Disease—CYBA—atherosclerosis	4.02e-05	0.000245	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.02e-05	0.000245	CbGpPWpGaD
Clodronate—PTGS2—Disease—PARP1—atherosclerosis	3.93e-05	0.00024	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NAMPT—atherosclerosis	3.9e-05	0.000237	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.88e-05	0.000236	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—LIPC—atherosclerosis	3.88e-05	0.000236	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APOC3—atherosclerosis	3.85e-05	0.000235	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—LDLR—atherosclerosis	3.83e-05	0.000233	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CETP—atherosclerosis	3.74e-05	0.000228	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3.67e-05	0.000224	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SCARB1—atherosclerosis	3.58e-05	0.000218	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.49e-05	0.000212	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—AKT1—atherosclerosis	3.45e-05	0.00021	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HMGCR—atherosclerosis	3.38e-05	0.000206	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCA1—atherosclerosis	3.01e-05	0.000184	CbGpPWpGaD
Clodronate—PTGS2—Disease—APOB—atherosclerosis	2.96e-05	0.00018	CbGpPWpGaD
Clodronate—PTGS2—Disease—LPL—atherosclerosis	2.82e-05	0.000172	CbGpPWpGaD
Clodronate—PTGS2—Disease—PRKCG—atherosclerosis	2.75e-05	0.000167	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HMOX1—atherosclerosis	2.59e-05	0.000157	CbGpPWpGaD
Clodronate—PTGS2—Disease—MTHFR—atherosclerosis	2.54e-05	0.000155	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APOB—atherosclerosis	2.48e-05	0.000151	CbGpPWpGaD
Clodronate—PTGS2—Disease—PDGFB—atherosclerosis	2.47e-05	0.000151	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTM1—atherosclerosis	2.41e-05	0.000147	CbGpPWpGaD
Clodronate—PTGS2—Disease—APOE—atherosclerosis	2.37e-05	0.000144	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—LPL—atherosclerosis	2.37e-05	0.000144	CbGpPWpGaD
Clodronate—PTGS2—Disease—CAV1—atherosclerosis	2.35e-05	0.000143	CbGpPWpGaD
Clodronate—PTGS2—Disease—APOA1—atherosclerosis	2.34e-05	0.000142	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GPX1—atherosclerosis	2.31e-05	0.000141	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CD36—atherosclerosis	2.25e-05	0.000137	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOS2—atherosclerosis	2.21e-05	0.000134	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MTHFR—atherosclerosis	2.13e-05	0.00013	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PPARA—atherosclerosis	2.09e-05	0.000127	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—AGT—atherosclerosis	2.02e-05	0.000123	CbGpPWpGaD
Clodronate—PTGS2—Disease—INS—atherosclerosis	2.02e-05	0.000123	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APOE—atherosclerosis	1.98e-05	0.000121	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CAV1—atherosclerosis	1.96e-05	0.00012	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APOA1—atherosclerosis	1.96e-05	0.000119	CbGpPWpGaD
Clodronate—PTGS2—Disease—SERPINE1—atherosclerosis	1.86e-05	0.000113	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CG—atherosclerosis	1.79e-05	0.000109	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOS3—atherosclerosis	1.77e-05	0.000108	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PPARG—atherosclerosis	1.73e-05	0.000105	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—INS—atherosclerosis	1.69e-05	0.000103	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALB—atherosclerosis	1.55e-05	9.45e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NOS3—atherosclerosis	1.49e-05	9.04e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—STAT3—atherosclerosis	1.27e-05	7.7e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MAPK3—atherosclerosis	1.21e-05	7.36e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—TGFB1—atherosclerosis	1.17e-05	7.14e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—IL6—atherosclerosis	8.84e-06	5.38e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—AKT1—atherosclerosis	8.15e-06	4.96e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—AKT1—atherosclerosis	6.83e-06	4.16e-05	CbGpPWpGaD
